FDA panel considers a first-of-its-kind flu vaccine using mRNA technology

CityNews Toronto

WASHINGTON (AP) — U.S. health advisers are debating a new kind of flu vaccine Thursday, the first made with the same mRNA technology that was key to ending the COVID-19 pandemic.

Moderna is seeking Food and Drug Administration approval of its new shot, dubbed mFlusiva, as an option for people 50 and older.

The FDA […] ...

전문 보기

이 뉴스, 독자들은 어떻게 느꼈나요?

첫 반응을 남겨보세요

로그인하면 감정 반응에 참여할 수 있어요.

공식 발표 ↔ 진영별 보도

진보 성향 25%중도 성향 50%보수 성향 25%

1건2건1건

공식 발표 (3건) — 공공 라이선스 원문 직접 열람

진보 성향1

중도 성향2

보수 성향1

관련 뉴스 제보는 로그인 후 가능합니다.

'world' 카테고리 뉴스

CityNews의 다른 기사

MPs pass spending bill, opt to head home for summer break

CityNews Toronto

Ebola cases increase almost 40% in a week as death toll passes 200

CityNews Toronto

Grim anniversary: Police appeal for information to help solve Pickering teen’s 2023 murder

CityNews Toronto

FDA panel considers a first-of-its-kind flu vaccine using mRNA technology

이 뉴스, 독자들은 어떻게 느꼈나요?

공식 발표 ↔ 진영별 보도

'world' 카테고리 뉴스

Our Ocean Conference: Poe champions PH progress and surging biodiversity

Legarda marks Rizal’s 165th birth anniversary with call for unity

Pulong Duterte claps back at Remulla over ‘high’ remark: Get a mirror

CityNews의 다른 기사

MPs pass spending bill, opt to head home for summer break

Ebola cases increase almost 40% in a week as death toll passes 200

Grim anniversary: Police appeal for information to help solve Pickering teen’s 2023 murder